Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Subscription Receivable [Member]
Deferred Compensation, Share-Based Payments [Member]
Retained Earnings [Member]
Long-Lived Asset, Class [Axis]
Vehicles [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Antidilutive Securities [Axis]
Convertible Debt Securities [Member]
Warrant [Member]
Share-Based Payment Arrangement, Option [Member]
Restricted Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Securities Purchase Agreement [Member]
Title and Position [Axis]
Streeterville [Member]
Measurement Input Type [Axis]
Measurement Input, Expected Term [Member]
Financial Instrument [Axis]
Derivative 1 [Member]
Award Type [Axis]
Instrument Inception Measurement [Member]
Derivative 2 [Member]
Derivative 3 [Member]
Derivative 4 [Member]
Measurement Input, Share Price [Member]
Measurement Input, Option Volatility [Member]
Measurement Input, Risk Free Interest Rate [Member]
Measurement Input, Discount Rate [Member]
Remeasure At Each Reporting [Member]
Convertible Note 1 [Member]
Convertible Note 2 [Member]
Convertible Note 3 [Member]
Convertible Note 4 [Member]
Equipment [Member]
Leasehold Improvements [Member]
Construction in Progress [Member]
Operating Lease Agreement [Member]
Ground Robot Leases [Member]
Intangible Asset, Finite-Lived, Class [Axis]
Patents [Member]
Lease Contractual Term [Axis]
2026 [Member]
Prepaid Purchase Agreements [Member]
Pre-Delivery Shares [Member]
Host Debt Instrument [Member]
Debt Instrument [Axis]
Note Issuance Summary [Member]
Vehicle Note Payable [Member]
Daniel O Toole [Member]
Plan Name [Axis]
2023 Equity Incentive Plan [Member]
Accredited Investor [Member]
Other Investors [Member]
Employees and Consultants [Member]
Consultant [Member]
2023 Equity Incentive Plan [Member]
Restricted Stock Units (RSUs) [Member]
Geographical [Axis]
UNITED STATES
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Concentration Risk Type [Axis]
Geographic Concentration Risk [Member]
Customer [Axis]
One Customer [Member]
Customer Concentration Risk [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Legal Entity [Axis]
Streeterville Capital LLC [Member]
Individual [Axis]
Mark Hamm [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Listing, Par Value Per Share
Statement of Financial Position [Abstract]
ASSETS
CURRENT ASSETS
Cash and cash equivalents
Investments at fair value
Accounts receivable, net of allowance
Prepaid expenses
Other current assets
Total current assets
OTHER ASSETS
Property and equipment, net
Right of use assets - operating leases
Patents, net of accumulated amortization of $3,120 and $2,603
Deferred offering costs
Other assets
Total other assets
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable
Accrued expenses
Operating lease liability
Derivative liabilities
Convertible note payable, net of discount and debt issuance costs of $4,507,852 and $350,794, and $3,379,447 and $240,896, respectively
Note payable
Total current liabilities
LONG TERM LIABILITIES
Operating lease liability
Note payables, net of current portion
Total long term liabilities
Total liabilities
Commitments and Contingencies (See Note 16)
STOCKHOLDERS’ EQUITY
Common stock, $0.0002 par value, 200,000,000 authorized, 37,731,391 and 34,213,387 issued and outstanding at March 31, 2026 and December 31, 2025
Additional paid-in capital
Deferred compensation
Accumulated deficit
Total stockholders’ equity
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
Patents, net of accumulated amortization
Convertible note payable, net of discount
Debt issuance costs
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
REVENUE
OPERATING EXPENSES
General and administrative
Research and development
Sales and marketing
Total operating expenses
OTHER INCOME (EXPENSES)
Interest expense
Other income
Change in fair value of derivative liabilities
Accretion of debt discount
Loss on conversion of convertible notes payable
Realized gain on investments
Unrealized loss on investments
Total other income (expenses)
NET LOSS BEFORE TAXES
PROVISION (BENEFIT) FOR INCOME TAXES
NET LOSS
NET LOSS PER SHARE:
Basic
Diluted
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING:
Basic
Diluted
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Issuance of common stock and warrants for cash
Issuance of common stock and warrants for cash, shares
Issuance of common stock for deferred offering costs
Issuance of common stock for deferred offering costs, shares
Stock-based compensation
Stock-based compensation, shares
Net loss
Issuance of common stock for deferred compensation
Issuance of common stock for deferred compensation, shares
Issuance of common stock under stock plans
Issuance of common stock under stock plans, shares
Shares withheld for taxes upon vesting of restricted stock units
Shares withheld for taxes upon vesting of restricted stock units, shares
Issuance of common stock for the conversion of convertible notes payable
Issuance of common stock for the conversion of convertible notes payable, shares
Reclassification of derivative liabilities upon conversion of convertible notes payable
Reclassification of deferred offering costs upon financing drawdown
Balance
Balance, shares
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES
Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation
Depreciation and amortization
Credit loss expense
Operating lease liability - non-cash adjustment
Change in fair value of derivative liability
Loss on conversion of convertible notes payable
Accretion of discount on convertible note payable
Accretion of issuance costs on convertible note payable
Realized gain on investments
Unrealized loss on investments
Changes in operating assets and liabilities
Increase (decrease) in
Accounts receivable
Prepaid expenses
Other current assets
Other assets
Accounts payable
Accrued expenses
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures
Proceeds from sales of investments
Purchase of investments
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from sale of common stock, net
Taxes paid for shares withheld upon vesting of restricted stock units
Proceeds from the exercise of warrants, net
Repayments of note payables
Proceeds from issuance of convertible notes payable
Debt issuance costs
Net cash provided by financing activities
NET INCREASE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
CASH AND CASH EQUIVALENTS, END OF PERIOD
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for:
Interest
Income taxes
SUPPLEMENTAL DISCLOSURE OF NONCASH INFORMATION
Common stock issued as payment of offering costs
Common stock issued for deferred compensation
Common stock issued for conversion of convertible notes payable
Derivative liabilities reclassified as additional paid-in capital upon conversion of convertible notes payable
Deferred offering costs recognized as additional paid-in capital upon financing drawdown
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Trading Arrangements, by Individual [Table]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES
Revenue from Contract with Customer [Abstract]
REVENUE
LIQUIDITY AND GOING CONCERN
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS
Property, Plant, and Equipment [Abstract]
PROPERTY AND EQUIPMENT
Leases
LEASES
Intangible Asset, Goodwill and Other [Abstract]
PATENTS, NET
Deferred Offering Costs
DEFERRED OFFERING COSTS
Debt Disclosure [Abstract]
CONVERTIBLE NOTES PAYABLE
NOTE PAYABLE
Related Party Transactions [Abstract]
RELATED-PARTY TRANSACTIONS
Equity [Abstract]
STOCKHOLDERS’ EQUITY (DEFICIT)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
WARRANTS
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Segment Reporting [Abstract]
SEGMENT REPORTING
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of Presentation
Use of Estimates
Cash and Cash Equivalents
Concentration of Credit Risk
Investments at Fair Value
Accounts Receivable and Allowance for Credit Losses
Property and Equipment
Intangible Assets – Patents
Impairment of Long-Lived Assets
Revenue Recognition
Contract Balances
Leases
Equity Financing
Loss per share
Comprehensive Loss
Offering Costs
Research and Development
Advertising Costs
Stock-Based Compensation
Convertible Notes Payable and Derivative Liabilities
Income Taxes
Recently Adopted Accounting Pronouncements
Recently Issued Accounting Pronouncements Not Yet Adopted
SCHEDULE OF DILUTIVE SECURITIES
SCHEDULE OF FINANCE LIABILITIES MEASURED AT FAIR VALUE
SCHEDULE OF VALUATION OF MEASUREMENT INPUT
SCHEDULE OF RECONCILIATION OF THE DERIVATIVE LIABILITIES MEASURED AT FAIR VALUE
SCHEDULE OF PROPERTY AND EQUIPMENT
SCHEDULE OF RIGHT-OF-USE ASSETS AND LEASE LIABILITIES
SCHEDULE OF LEASE COST
SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS
SCHEDULE OF PATENTS
SCHEDULE OF DEFERRED OFFERING COSTS
SCHEDULE OF FAIR VALUE REMEASUREMENT OF THE DERIVATIVE LIABILITY
SCHEDULE OF CONVERTIBLE NOTE PAYABLE
SCHEDULE OF OTHER INCOME AND EXPENSES RELATED TO THE CONVERTIBLE NOTES
SCHEDULE OF NOTES PAYABLE
SCHEDULE OF MATURITIES OF LONG-TERM DEBT
SCHEDULE OF WARRANTS OUTSTANDING
SCHEDULE OF SHARE OPTIONS OUTSTANDING
SCHEDULE OF NONVESTED SHARE OPTION
SCHEDULE OF RESTRICTED STOCK UNITS OUTSTANDING
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total excluded shares
Property, Plant, and Equipment [Table]
Property, Plant, and Equipment [Line Items]
Cash
Uninsured cash balance
Allowance for credit losses
Property, plant and equipment, useful life
Impairment loss of long-lived assets
Advertising costs
Share price
Revenue
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Short-term investments
Convertible note payable
Market capitalization
Management fees
Gross borrowings
Cash, cash equivalents, and short-term investments
Fair Value Measurement Inputs and Valuation Techniques [Table]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assumed instrument term
Measurement input
Derivative Liability, Measurement Input
Fair Value, off-Balance-Sheet Risk [Table]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Balance
Derivative liability recognized upon issuance of convertible note payable at fair value
Reclassification of derivative liabilities upon conversion of convertible notes payable
Change in fair value of derivative liabilities – conversion remeasurement
Change in fair value — period-end remeasurement (March 31, 2026)
Balance
Share price
Change in fair value of derivative liability
Realized gain on investment
Unrealized loss on investment
Total property and equipment
Less: accumulated depreciation
TOTAL PROPERTY AND EQUIPMENT, NET
Depreciation expenses
Schedule Of Right-of-use Assets And Lease Liabilities
Right-of-use assets, net
Operating lease liabilities – current portion
Operating lease liabilities – long-term portion
Schedule Of Lease Cost
Operating lease cost included in general and administrative expense
Cash paid for amounts included in the measurement of operating lease liabilities
Right-of-use assets obtained in exchange for lease obligations
Remainder of 2026
2027
2028
2029
2030
Total future lease payments
Less: Amount representing interest
Present value of lease liabilities
Less: current portion
Long-term portion
Base rent
Monthly rent percentage
Operating lease cost
Variable lease costs
Lease payments
Operating lease description
Weighted-average remaining lease term
Weighted-average discount rate
Patents
Less: accumulated amortization
TOTAL PATENTS
Intangible Asset, Finite-Lived [Table]
Intangible Asset, Finite-Lived [Line Items]
Intangible Asset, Finite-Lived, Remaining Amortization Period
Intangible Asset, Finite-Lived, Amortization Expense
Schedule Of Deferred Offering Costs
Beginning balance
Costs related to public offering
Costs related to crowdfunding
Reclassification to additional paid-in capital
OUTSTANDING BALANCE
Gross proceeds
Debt instrument face amount
Deferred offering costs as reduction of additional paid-in capital
Deferred offering costs
Short-Term Debt [Table]
Short-Term Debt [Line Items]
Issuance date
Face amount
Original issue discount
Cash proceeds
Debt issuance costs (contra-liability)
Derivative discount (initial fair value of bifurcated derivatives)
Commitment shares (discount)
INITIAL HOST CARRYING VALUE
Balance at January 1, 2026
Note issuance — initial host carrying value
EIM accretion of debt discount and issuance costs
Conversions — face amount
Conversions — issuance costs
Conversions — unamortized discount
HOST CARRYING VALUE AT MARCH 31, 2026
Stated interest at 8% per annum
Accretion of debt discount
Accretion of debt issuance costs
Loss on conversion of convertible notes payable
Interest rate stated, percentage
Vehicle note payable for $40,248 with monthly installment payments of $799, including interest at 6.99% per annum. The loan is collateralized by the respective vehicle and is due in February 2027.
Less current portion
LONG-TERM PORTION
Vehicle note payable
Monthly installments
2026
2027
TOTAL
Convertible note payable
Remaining undrawn capacity
Bear interest rate
Number of purchased shares of common stock
Share price per share
Aggregate consideration
Original issue discount rate
Debt issuance costs rate
Proceeds from Notes Payable
Derivative components and expense
Contra-liability
Interest expenses
Related Party Transaction [Table]
License fee
Price per unit
Related party transactions, description
Licensing fee costs
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shres issued
Number of shares issued of service
Number of shares issued of service, value
Compensation expenses
Number of shares issued
Surrender of restricted stock units for taxes, shares
Payroll taxes
Number of shares conversion of convertible notes payable
Number of shares conversion of convertible notes payable, value
Number of shares issued, value
Share price
Number of shares deemed
Number of warrants exercised
Cash proceeds
Number of restricted shares issued
Number of shares issued, value
Stock repurchase
Number of shares repurchased
Number of shares repurchased, value
Number of retired shares
Number of warrants, outstanding
Weighted average exercise price, outstanding
Weighted average grant date fair value, outstanding
Weighted average remaining contractual term (years)
Aggregate intrinsic value
Number of warrants, granted
Weighted average exercise price, granted
Weighted average grant date fair value, granted
Number of warrants, exercised
Weighted average exercise price, exercised
Weighted average grant date fair value, exercised
Number of warrants, cancelled/expired
Weighted average exercise price, cancelled/expired
Weighted average grant date fair value, cancelled/expired
Number of warrants, outstanding
Weighted average exercise price, outstanding
Weighted average grant date fair value, outstanding
Aggregate intrinsic value
Number of warrants, exercisable
Weighted average exercise price, exercisable
Weighted average grant date fair value, exercisable
Weighted average remaining contractual term (years), exercisable
Aggregate intrinsic value, exercisable
Warrants exercise price
Number of share options outstanding
Weighted average exercise price
Weighted average grant date fair value
Weighted average remaining contractual life years
Aggregate intrinsic value
Share options outstanding granted
Weighted average exercise price granted
Weighted average grant date fair value granted
Share options outstanding exercised
Weighted average exercise price exercised
Weighted average grant date fair value canceled/expired
Share options outstanding canceled/expired
Weighted average exercise price canceled/expired
Weighted average grant date fair value canceled/expired
Number of share options outstanding
Weighted average exercise price
Weighted average grant date fair value
Aggregate intrinsic value
Number of share options, vested and expected to vest
Weighted average exercise price, vested and expected to vest
Weighted average grant date fair value, vested and expected to vest
Weighted average remaining contractual life years, vested and expected to vest
Aggregate intrinsic value, vested and expected to vest
Number of shares exercisable
Weighted average exercise price, exercisable
Weighted average grant date fair value, exercisable
Weighted average remaining contractual term (years), exercisable
Aggregate intrinsic value, exercisable
Number of nonvested share options
Weighted average exercise price
Weighted average grant date fair value
Weighted average remaining contractual life years
Aggregate intrinsic value
Nonvested share options, granted
Weighted average grant date fair value, vested
Weighted average grant date fair value, granted
Nonvested share options, vested
Weighted average grant date fair value, vested
Weighted average grant date fair value, vested
Weighted average remaining contractual life years, vested
Aggregate intrinsic value, vested
Nonvested share options, canceled/expired
Weighted average grant date fair value, canceled/expired
Weighted average grant date fair value, canceled/expired
Number of nonvested share options
Weighted average exercise price
Weighted average grant date fair value
Aggregate intrinsic value
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of restricted stock units, outstanding beginning
Weighted average grant date fair value, outstanding beginning
Number of restricted stock units, granted
Weighted average grant date fair value, granted
Number of restricted stock units, vested
Weighted average grant date fair value, vested
Number of restricted stock units, canceled/expired
Weighted average grant date fair value, canceled/expired
Number of restricted stock units, outstanding ending
Weighted average grant date fair value, outstanding ending
Common stock availble for issuance
Availble for grant
Stock prices
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Performance based compensation expenses
Number of shares issued to employee
Total fair value
Number of shares vested
Number of shares canceled
Share based compensation
Performance obligation vested
Performance obligation vested period
Performance-based restricted stock units cancelled, shares
Unrecognized share-based compensation expense
Liability for Unpaid Claims and Claims Adjustment Expense, Net
Plaintiff's alleged damages and fees
Segment Reporting [Table]
Segment Reporting [Line Items]
Number of reportable segments
Concentration risk percentage
Subsequent Event [Table]
Subsequent Event [Line Items]
Debt conversion
Debt conversion, shares
Accretion of debt discount.
Loss on conversion of convertible notes payable
Subscription Receivable [Member]
Issuance of common stock and warrants, value.
Issuance of common stock and warrants, shares.
Issuance of common stock for deferred offering costs, value.
Issuance of common stock for deferred offering costs, shares.
Operating lease liability non cash adjustment.
Accretion of issuance costs on convertible notes payable.
Cash Paid [Abstract]
Common stock issued as payment of offering costs.
Common stock issued for conversion of convertible notes payable.
Derivative liabilities reclassified as additional paid in capital upon conversion of convertible notes payable
Deferred offering costs recognized as additional paid-in capital upon financing drawdown.
Contract Balances [Policy Text Block]
Offering Costs [Policy Text Block]
Share-based compensation arrangement by share-based payment award options fair value of price per shares
Convertible Notes Payable And Derivative Liabilities [Policy Text Block]
New Accounting Pronouncements Not Yet Adopted Policy [Policy Text Block]
Securities Purchase Agreement [Member]
Management fees.
Streeterville [Member]
Derivative 1 [Member]
Instrument Inception Measurement [Member]
Derivative 2 [Member]
Derivative 3 [Member]
Derivative 4 [Member]
Remeasure At Each Reporting [Member]
Convertible Note 1 [Member]
Convertible Note 2 [Member]
Convertible Note 3 [Member]
Convertible Note 4 [Member]
Derivative fair value at issuance.
Change in fair value of derivative liabilities conversion remeasurement
Operating Lease Agreement [Member]
Monthly rent percentage.
Variable lease costs.
Ground Robot Leases [Member]
Schedule of Right-of-use Assets and Lease Liabilities [Table Text Block]
Right of use assets obtained in exchange for lease obligations.
Two Thousand Twenty Six [Member]
Deferred Offering Costs [Text Block]
Prepaid Purchase Agreements [Member]
Schedule Of Deferred Offering Costs [Table Text Block]
Deferred offering costs current and non-current.
Deferred offering costs costs related to public offering.
Deferred offering costs costs related to crowd funding.
Deferred offering costs reclassification to additional paid in capital.
Remaining undrawn capacity.
Pre-Delivery Shares [Member]
Original issue discount rate.
Host Debt Instrument [Member]
Debt issuance costs rate.
Note Issuance Summary [Member]
Derivative components and expense.
Contraliability.
Debt issuance costs.
Initial host carrying value.
EIM accretion of debt discount and issuance costs.
Conversions face amount
Conversions issuance costs
Conversions unamortized discount
Accretion of debt issuance costs (Interest expense).
Loss on conversion of convertible note payable
Vehicle note payable.
Vehicle Note Payable [Member]
Contractual payment per unit sold.
2023 Equity Incentive Plan [Member]
Stock issued during period shares deemed.
Stock issued during period shares warrants exercised.
Other Investors [Member]
Employees and Consultants [Member]
Consultant [Member]
Common stock availble for issuance.
2023 Equity Incentive Plan [Member]
One Customer [Member]
Streeterville Capital LLC [Member]
Share based compensation arrangement by share based payment award options weighted average grant date fair value.
Share based compensation arrangement by share based payment award options granted in period.
Share based compensation arrangement by share based payment award options exercised in period .
Share based compensation arrangements by share based payment award options granted in period weighted average exercise price.
Share based compensation arrangement by share based payment award options exercised in period weighted average exercise price.
Share based compensation arrangement by share based payment award options granted in period weighted average grant date fair value.
Share based compensation arrangement by share based payment award options exercised in period weighted average grant date fair value.
Share based compensation arrangement by share based payment award options exercisable weighted average grant date fair value.
Sharebased compensation arrangement by sharebased payment award options nonvested weighted average exercise price.
Sharebased compensation arrangement by sharebased payment award options outstanding weighted average remaining contractual term.
Sharebased compensation arrangement by sharebased payment award options nonvested exercisable intrinsic value one.
Share based compensation arrangement by share based payment award option non vested granted weighted average exercise price.
Sharebased compensation arrangement by sharebased payment award option non vested weighted average exercise price.
Sharebased compensation arrangement by sharebased payment award option non vested forfeited weighted average exercise price.
Weighted average remaining contractual life years, vested.
Aggregate intrinsic value, vested.
Stock option canceled.
Mark Hamm [Member]
Schedule of Fair Value Remeasurement of the Derivative Liability [Table Text Block]
Debt instrument original issue discount.
Derivative discount.
Commitment shares discount.
Note issuance initial host carrying value.
Schedule of Other Income and Expenses Related to the Convertible Notes [Table Text Block]
Payment for license fees.
Daniel O Toole [Member]
Licensing fee costs.
Accredited Investor [Member]
Share based compensation arrangement by share based payment award non option equity instruments exercisable.
Share based compensation arrangement by share based payment award equity instruments non option outstanding weighted average exercise price.
Share based compensation arrangement by share based payment award equity instruments non option grants in period weighted average exercise price.
Share based compensation arrangement by share based payment award equity instruments non option exercised in period weighted average exercise price.
Share based compensation arrangement by share based payment award equity instruments non option forfeited in period weighted average exercise price.
Share based compensation arrangement by share based payment award equity instruments non option weighted average exercisable price.
Share based compensation arrangement by share based payment award equity instruments non option nonvested weighted average grant date fair value.
Share based compensation arrangement by share based payment award equity instruments non option grants in period weighted average grant date fair value.
Share based compensation arrangement by share based payment award equity instruments non option exercised weighted average grant date fair value.
Share based compensation arrangement by share based payment award equity instruments non option forfeitures weighted average grant date fair value.
Share based compensation arrangement by share based payment award equity instruments non option exercisable weighted average grant date fair value.
Share based compensation arrangement by share based payment award equity instruments non option outstanding weighted sverage remaining contractual terms
Share based compensation arrangement by share based payment award equity instruments non option outstanding exercisable weighted average remaining contractual terms.
Share based compensation arrangement by sharebased payment award equity instruments non option aggregate intrinsic value outstanding.
Share based compensation arrangement by share based payment award equity instruments non option exercisable aggregate intrinsic value outstanding.
Share based compensation arrangements by share based payment award options expirations in period weighted average grant date fair value.
Share based compensation arrangement by share based payment award equity instruments other than options cancelled in period weighted average grant date fair value.
Deferred compensation.
Common stock issued for deferred compensation.
Weighted average grant date fair value, vested and expected to vest.
2023 Equity Incentive Plan [Member] [Default Label]
Assets, Current
Assets, Noncurrent
Assets
Liabilities, Current
Liabilities, Noncurrent
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Operating Expenses
Other Nonoperating Expense
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Income Tax Expense (Benefit)
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Diluted
Shares, Outstanding
Stock Issued During Period, Value, Other
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Prepaid Expense
Increase (Decrease) in Other Current Assets
Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Accrued Liabilities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Investments
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Payment, Tax Withholding, Share-Based Payment Arrangement
Repayments of Notes Payable
Payments of Debt Issuance Costs
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Revenue from Contract with Customer [Text Block]
Lessee, Leases [Policy Text Block]
Share Price
Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Intangible Asset, Finite-Lived, Accumulated Amortization
DeferredOfferingCostsCurrentAndNoncurrent
DebtIssuanceCosts
ConversionsFaceAmount
LossOnConversionOfConvertibleNotePayable
Notes Payable, Current
Long-Term Debt, Maturity, Year One
Proceeds from Issuance of Warrants
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionOutstandingWeightedAverageExercisePrice
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionNonvestedWeightedAverageGrantDateFairValue
ShareBasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionAggregateIntrinsicValueOutstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionWeightedAverageExercisablePrice
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionExercisableWeightedAverageGrantDateFairValue
ShareBasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionExercisableAggregateIntrinsicValueOutstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageGrantDateFairValue
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriod
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageGrantDateFairValue
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice
Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedExercisableIntrinsicValue1
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionNonVestedWeightedAverageExercisePrice
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value